Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
A20 Restrains Thymic Regulatory T Cell Development
Ist Teil von
The Journal of immunology (1950), 2017-10, Vol.199 (7), p.2356-2365
Ort / Verlag
United States: American Association of Immunologists
Erscheinungsjahr
2017
Link zum Volltext
Quelle
MEDLINE
Beschreibungen/Notizen
Maintaining immune tolerance requires the production of Foxp3-expressing regulatory T (T
) cells in the thymus. Activation of NF-κB transcription factors is critically required for T
cell development, partly via initiating Foxp3 expression. NF-κB activation is controlled by a negative feedback regulation through the ubiquitin editing enzyme A20, which reduces proinflammatory signaling in myeloid cells and B cells. In naive CD4
T cells, A20 prevents kinase RIPK3-dependent necroptosis. Using mice deficient for A20 in T lineage cells, we show that thymic and peripheral T
cell compartments are quantitatively enlarged because of a cell-intrinsic developmental advantage of A20-deficient thymic T
differentiation. A20-deficient thymic T
cells exhibit reduced dependence on IL-2 but unchanged rates of proliferation and apoptosis. Activation of the NF-κB transcription factor RelA was enhanced, whereas nuclear translocation of c-Rel was decreased in A20-deficient thymic T
cells. Furthermore, we found that the increase in T
cells in T cell-specific A20-deficient mice was already observed in CD4
single-positive CD25
GITR
Foxp3
thymic T
cell progenitors. T
cell precursors expressed high levels of the tumor necrosis factor receptor superfamily molecule GITR, whose stimulation is closely linked to thymic T
cell development. A20-deficient T
cells efficiently suppressed effector T cell-mediated graft-versus-host disease after allogeneic hematopoietic stem cell transplantation, suggesting normal suppressive function. Holding thymic production of natural T
cells in check, A20 thus integrates T
cell activity and increased effector T cell survival into an efficient CD4
T cell response.